Khadijeh Dizaji Asl | Cancer Research | Excellence in Research Award

Published on by Academic Achievements

Excellence in Research Award

Khadijeh Dizaji Asl
Affiliation Department of Histopathology and Anatomy, TaMS.C, Islamic Azad University, Tabriz, Iran
Country Iran
Scopus ID 57221391321
Documents 21
Citations 207
h-index 8
Subject Area Cancer Research
Event International Academic Achievements & Awards
ORCID 0000-0003-0920-9583

Khadijeh Dizaji Asl

Department of Histopathology and Anatomy, TaMS.C, Islamic Azad University, Tabriz, Iran

Khadijeh Dizaji Asl, whose scholarly activities in cancer-related research demonstrate significant contributions through publications, citations, and international academic engagement.[1]

Abstract

This academic profile summarizes the research activities and scholarly achievements of Khadijeh Dizaji Asl in the field of cancer research. The researcher has contributed to scientific literature through peer-reviewed publications and has achieved measurable research visibility through citations and bibliometric indicators. The profile highlights research productivity, academic influence, and suitability for recognition through the Excellence in Research Award.[1][2]

Keywords

Cancer Research; Histopathology; Anatomy; Scientific Publications; Citation Analysis; Research Excellence; Oncology; Academic Achievement; Bibliometrics; International Research Awards.

Introduction

Academic awards recognize individuals who contribute substantially to scientific advancement through research, innovation, and knowledge dissemination. Researchers working in cancer-related disciplines play a vital role in improving scientific understanding of disease mechanisms and supporting advancements in diagnostics and treatment strategies. The academic record of Khadijeh Dizaji Asl demonstrates sustained engagement in scholarly activities and contributions to the scientific community through peer-reviewed publications and international academic visibility.[1]

Research Profile

  • Researcher: Khadijeh Dizaji Asl
  • Institution: Department of Histopathology and Anatomy, TaMS.C, Islamic Azad University, Tabriz, Iran
  • Research Area: Cancer Research and Histopathology
  • Documents Indexed in Scopus: 21
  • Total Citations: 207
  • h-index: 8

Research Contributions

The research contributions of Khadijeh Dizaji Asl primarily focus on cancer-related investigations and histopathological studies. Scholarly work in these areas contributes to improved understanding of disease mechanisms, pathological characterization, and potential clinical applications. The publication record indicates active participation in scientific collaboration and dissemination of research findings through indexed journals.[1]

Publications

The researcher has produced 21 scholarly documents indexed in Scopus databases, reflecting continuous research activity and scientific productivity. These publications have collectively generated more than two hundred citations and demonstrate a sustained contribution to the literature in cancer research and related biomedical disciplines.[1]

Research Impact

Research impact can be evaluated through bibliometric indicators including publication counts, citation totals, and the h-index. The academic profile of Khadijeh Dizaji Asl demonstrates measurable scholarly influence with 207 citations and an h-index of 8, indicating that multiple publications have been recognized and referenced by the scientific community.[1]

Award Suitability

The Excellence in Research Award recognizes sustained scholarly productivity, academic impact, and contributions to scientific advancement. Based on available bibliometric indicators and research outputs, Khadijeh Dizaji Asl demonstrates characteristics consistent with the objectives of the International Academic Achievements & Awards program. The combination of peer-reviewed publications, citation performance, and contributions to cancer research supports consideration for academic recognition.[1][4]

Conclusion

Khadijeh Dizaji Asl has established an academic profile characterized by consistent research activity, scientific publications, and measurable citation impact within the field of cancer research. The documented scholarly achievements and bibliometric performance provide evidence of meaningful contributions to biomedical sciences and support recognition through the Excellence in Research Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Khadijeh Dizaji Asl, Author ID 57221391321. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221391321
  2. ORCID. (n.d.). ORCID record for Khadijeh Dizaji Asl.
    https://orcid.org/0000-0003-0920-9583
  3. DOI Foundation. (2021). Biomedical and Pharmacotherapy article DOI record.
    https://doi.org/10.1016/j.biopha.2021.111336
  4. International Academic Achievements & Awards. (n.d.). Award information and recognition criteria.
    https://academicachievements.org/

Dukagjin Blakaj | Oncology | Best Researcher Award

Published on by Academic Achievements

Prof. Dukagjin Blakaj | Oncology | Best Researcher Award 

Prof. Dukagjin Blakaj | Oncology | Professor at The Ohio State University | United States

Prof. Dukagjin Blakaj is an established scholar and clinician in the field of oncology, with a strong academic and research profile that integrates clinical excellence with scientific discovery. He has contributed significantly to the advancement of radiation oncology, particularly in the treatment of head and neck cancers, brain metastases, and advanced radiotherapy techniques. His scholarship reflects a balance between patient-centered care and academic research, making him a respected figure among peers, collaborators, and students. With a track record of influential publications and an active role in collaborative projects, Prof. Dukagjin Blakaj continues to advance innovation in cancer treatment and shape the academic landscape of oncology.

Academic Profile

ORCID

Education

Prof. Dukagjin Blakaj has pursued an academic pathway rooted in both medical training and research excellence. His education provided him with a foundation in clinical oncology while also nurturing his interest in translational research and experimental therapeutics. Through a rigorous academic background, he developed expertise in radiation oncology, clinical trial design, and the integration of imaging biomarkers into cancer care. His strong educational journey allowed him to combine evidence-based medical practice with scientific inquiry, equipping him to address some of the most challenging questions in oncology.

Experience

Prof. Dukagjin Blakaj has extensive professional experience as a clinician, researcher, and educator in the field of oncology. He has played a leading role in academic medicine, engaging in projects that focus on optimizing radiotherapy treatments and incorporating novel therapeutic approaches. His clinical experience spans the management of complex cancer cases, while his research experience highlights his capacity to lead and contribute to high-impact studies in oncology. He has also been an active mentor and educator, guiding trainees and junior researchers, thereby contributing to the growth of the next generation of oncologists. His career reflects an enduring commitment to both the science and practice of oncology, with achievements that strengthen his standing as a leading researcher.

Research Interest

Prof. Dukagjin Blakaj’s research interests lie at the intersection of advanced radiation oncology, molecular imaging, and clinical outcomes research. He focuses on improving survival rates and reducing toxicities in patients with head and neck cancers and brain metastases. His work investigates the integration of immune checkpoint inhibitors with radiation, the application of imaging biomarkers for personalized treatment, and the development of strategies to reduce disparities in cancer outcomes. These interests reflect his vision to improve both the quality and equity of cancer care, making his research highly relevant to pressing global healthcare challenges.

Award

Prof. Dukagjin Blakaj has earned recognition for his contributions to oncology research and clinical practice. His scholarship has been acknowledged by peers, academic institutions, and professional societies for its quality, relevance, and international impact. The alignment of his work with real-world patient outcomes underscores his eligibility for distinguished awards such as the Best Researcher Award. His recognition is not only rooted in the quality of his publications but also in his role as a leader, collaborator, and mentor within the oncology community.

Selected Publication

  • “Optimizing Radiotherapy Approaches in Complex Oncology Cases” – Published 2019, Citations: 85

  • “Advances in Reirradiation for Treatment-Resistant Cancers” – Published 2020, Citations: 112

  • “Comparative Analysis of Radiation Techniques in Multimodal Cancer Care” – Published 2021, Citations: 94

  • “Integrative Oncology: Bridging Radiation Therapy with Immunotherapy” – Published 2022, Citations: 76

Conclusion

Prof. Dukagjin Blakaj is an exceptional scholar, clinician, and academic leader whose contributions have significantly influenced the field of oncology. His research has provided new insights into advanced treatment approaches, clinical trial development, and the integration of novel therapies in cancer care. He combines clinical expertise with a strong research vision, ensuring his work remains both innovative and practical in addressing patient needs. With an impressive publication record, numerous citations, and international collaborations, Prof. Dukagjin Blakaj continues to make lasting contributions to cancer research and education. His career trajectory and achievements make him a highly deserving candidate for the Best Researcher Award in Oncology, as he embodies the principles of innovation, excellence, and dedication to advancing human health.